ABANDONED - NO STATEMENT OF USE FILED
no statement of use filed
on 22 Sep 2014
Last Applicant/ Owned by
345 Park Avenue
New York
NY
10154
Serial Number
85890458 filed on 29th Mar 2013
Registration Number
N/A
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
CEEVOPEL
Pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, name Read More
Classification Information
Class [005]
Pharmaceutical Products
Pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants and pharmaceutical antibodies
Mark Details
Serial Number
No 85890458
Mark Type
No Service/Collective Mark
Attorney Docket Number
No
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 22nd Sep 2014 | ABANDONMENT - NO USE STATEMENT FILED |
| 22nd Sep 2014 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED |
| 18th Feb 2014 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| 24th Dec 2013 | PUBLISHED FOR OPPOSITION |
| 24th Dec 2013 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 04th Dec 2013 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 15th Nov 2013 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| 12th Nov 2013 | ASSIGNED TO LIE |
| 24th Oct 2013 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 14th Oct 2013 | CORRESPONDENCE RECEIVED IN LAW OFFICE |